Mohan Pankaj Insider Trades

Insider Trading History

Track insider trading activity for Mohan Pankaj. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings SONN
Chairman, President And CEO
Holding Value $18.9k 14,987 shares
Last Trade
Dec 11, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$87.6k 7,554 shares
$11.59
$1.26
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings SONN
Chairman, President And CEO
Holding Value $86.6k 68,750 shares
Last Trade
Oct 27, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$949k 103,125 shares
$9.20
$1.26
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings SONN
Chairman, President And CEO
Holding Value $697k 553,331 shares
Last Trade
May 15, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$14.6M 371,600 shares
$39.33
$1.26
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings SONN
Chairman, President And CEO
Holding Value $229k 181,731 shares
Last Trade
Mar 15, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.91M 60,000 shares
$98.50
$1.26
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings SONN
Chairman, President And CEO
Holding Value $60.7k 48,170 shares
Last Trade
Jan 07, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$16.7M 73,561 shares
$226.81
$1.26
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings SONN
Chairman, President And CEO
Holding Value $153k 121,731 shares
Last Trade
Jan 07, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16.7M 73,561 shares
$226.81
$1.26
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings SONN
Chairman, President And CEO
Holding Value $943k 748,606 shares
Last Trade
Dec 14, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13M 74,205 shares
$175.82
$1.26
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings SONN
Chairman, President And CEO
Holding Value $850k 674,401 shares
Last Trade
Dec 15, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$397M 320,135 shares
$1,239.38
$1.26
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings SONN
Chairman, President And CEO
Holding Value $446k 354,266 shares
Last Trade
Jun 09, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$121M 32,000 shares
$3,766.15
$1.26
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings SONN
Chairman, President And CEO
Holding Value $406k 322,266 shares
Last Trade
Jul 02, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.86B 319,866 shares
$8,935.38
$1.26
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings SONN
10% owner, Chairman, President And CEO
Holding Value $3.02k 2,400 shares
Last Trade
Jun 10, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$23.9M 2,400 shares
$9,944.61
$1.26
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings SONN
10% owner, Chairman, President And CEO
Holding Value $1.17M 930,705 shares
Last Trade
Apr 01, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.1B 930,705 shares
$21,552.80
$1.26
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings SONN
Chairman, President And CEO
Holding Value $2M 1,591,116 shares
Last Trade
Apr 01, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$91.9M 4,263 shares
$21,552.80
$1.26
Outlook Therapeutics- Warrants
Outlook Therapeutics- Warrants OTLKW
10% owner
Holding Value $212k 7,064,553 shares
Last Trade
Jan 15, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.32k 8,000 shares
$0.16
$0.03
Outlook Therapeutics
Outlook Therapeutics OTLK
10% owner
Holding Value $5.61M 7,064,553 shares
Last Trade
Jan 15, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$42.6k 8,000 shares
$5.32
$0.79
Outlook Therapeutics
Outlook Therapeutics OTLK
10% owner
Holding Value $90.7k 114,157 shares
Last Trade
Nov 09, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$102k 114,157 shares
$0.89
$0.79
Outlook Therapeutics- Warrants
Outlook Therapeutics- Warrants OTLKW
10% owner
Holding Value $3.42k 114,157 shares
Last Trade
Nov 09, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17k 114,157 shares
$0.15
$0.03
Outlook Therapeutics
Outlook Therapeutics OTLK
10% owner
Holding Value $11.9k 15,000 shares
Last Trade
Sep 21, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.8k 15,000 shares
$0.92
$0.79
Outlook Therapeutics- Warrants
Outlook Therapeutics- Warrants OTLKW
10% owner
Holding Value $450 15,000 shares
Last Trade
Sep 21, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$207 15,000 shares
$0.01
$0.03
Outlook Therapeutics- Warrants
Outlook Therapeutics- Warrants OTLKW
10% owner, President & CEO
Holding Value $212k 7,056,553 shares
Last Trade
Jan 04, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.5k 62,569 shares
$0.02
$0.03

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up